Extended use of cardiopulmonary bypass in a multidisciplinary hospital

Insights

Cardiopulmonary bypass (CPB) enables complex non-cardiac surgeries. This technique facilitates challenging procedures beyond traditional heart conditions, improving patient outcomes in specialized cases.

Area of Science:

  • Cardiovascular Surgery
  • Medical Technology

Background:

  • Cardiopulmonary bypass (CPB) is traditionally used for ischemic, congenital, and valvular heart diseases.
  • Its application in non-traditional cardiac and complex non-cardiac surgeries is less explored.

Purpose of the Study:

  • To document the experience of using CPB in non-traditional surgical scenarios.
  • To highlight the feasibility and utility of CPB beyond conventional cardiac procedures.

Main Methods:

  • A retrospective review of patients undergoing non-traditional cardiac surgery with CPB from 1999 to 2009.
  • Assessment of preoperative presentation, operative strategy, and postoperative status for identified cases.

Main Results:

  • Six cases utilized CPB for non-traditional indications, including aortic transection repair, PDA aneurysm repair, right atrial thrombus removal, carotid artery aneurysm repair, and posterior cranial fossa tumor resection.
  • Procedures were performed via left thoracotomy or with hypothermic circulatory arrest.
  • One patient experienced mortality after prolonged hospitalization; others had unremarkable recoveries.

Conclusions:

  • CPB can be extended to complex, technically challenging non-cardiac procedures in a multidisciplinary setting.
  • This approach facilitates surgeries that might otherwise be impossible, showcasing CPB's versatility.
Abstract

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
432
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
656
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
583
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
772